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Abstract 
Background:  Psoriasis and atopic dermatitis (AD) are chronic inflammatory skin diseases, which negatively influence 
the quality of life. In the last years, several evidences highlighted the pivotal role of skin bacteria in worsening the 
symptomatology of AD and psoriasis. In the present study we evaluated the skin microbiota composition in accu-
rately selected subjects affected by (AD) and psoriasis.
Methods: Three first cousins were chosen for the study according to strict selection of criteria. One subject was 
affected by moderate AD, one had psoriasis and the last one was included as healthy control. Two lesional skin sam-
ples and two non-lesional skin samples (for AD and psoriatic subjects) from an area of 2 cm2 behind the left ear were 
withdrawn by mean of a curette. For the healthy control, two skin samples from an area of 2 cm2 behind the left ear 
were withdrawn by mean of a curette. DNA was extracted and sequencing was completed on the Ion Torrent PGM 
platform. Culturing of Staphylococcus aureus from skin samples was also performed.
Results: The psoriatic subject showed a decrease in Firmicutes abundance and an increase in Proteobacteria abun-
dance. Moreover, an increase in Streptococcaceae, Rhodobacteraceae, Campylobacteraceae and Moraxellaceae has 
been observed in psoriatic subject, if compared with AD individual and control. Finally, AD individual showed a larger 
abundance of S. aureus than psoriatic and healthy subjects. Moreover, the microbiota composition of non-lesional 
skin samples belonging to AD and psoriatic individuals was very similar to the bacterial composition of skin sample 
belonging to the healthy control.
Conclusion: Significant differences between the skin microbiota of psoriatic individual and healthy and AD subjects 
were observed.
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Background
The largest organ of human body is the skin, which plays 
a pivotal role in protecting the host from pathogenic 
infections and penetration of harmful agents [1]. Before 
birth, the skin is completely sterile but after birth it is col-
onized by environmental microbes that are in homeosta-
sis with the host [2, 3]. Moreover, after a vaginal delivery, 
fecal and vaginal microbes belonging to the mother’s 
bacterial microflora also colonize the skin of infants. The 
microbial community living on the human skin is called 
skin microbiota, and it is constituted by over 100 distinct 
species of bacteria [4]. Generally, we find four dominant 
phyla of bacteria colonizing the skin: Actinobacteria, 
Proteobacteria, Firmicutes and Bacteroidetes [5]. Several 
evidences exist about the pivotal role of bacteria in the 
development and persistence of atopic dermatitis (AD), 
a chronic itchy, inflammatory skin condition, very com-
mon in childhood. AD is considered to be a multifacto-
rial disease, in which environmental and genetic factors 
contribute to its pathogenesis [1]. The incidence of AD 
has increased significantly in the last decades worldwide, 
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leading the scientific community to hypothesize that the 
change in the lifestyle and nutrition may be involved in 
the development of aforementioned disease [5–7]. In 
the majority of individuals affected by AD, Staphylococ-
cus aureus was found on the skin lesions. Furthermore, 
also the skin commensal Staphylococcus epidermidis 
has been observed to be increased with clinical disease 
activity, while bacteria belonging to the genera Strepto-
coccus, Propionibacterium and Corynebacterium were 
increased only after a pharmacological therapy [8]. The 
skin microbiota dysbiosis may lead to a lack of immune 
system stimulation, together with an imbalance of type 1 
T helper cells (TH1) and type 2 cells (TH2) activity, which 
might be involved in worsening of AD symptoms [9].
Psoriasis, instead, is a common inflammatory disease 
affecting 2–5 % of the population in industrialized coun-
tries. The disease is characterized by cutaneous inflam-
mation and keratinocyte hyperproliferation, and it is 
often linked to severe complications, such as psoriatic 
arthritis [1]. Psoriasis has been hypothesized to result 
from a lack of immune tolerance to the skin microbiota 
in genetically predisposed individuals [10]. The afore-
mentioned skin disease forms lesions on body often 
associated with beta-hemolytic streptococcal infection, 
where streptococcal superantigen leads T cell stimula-
tion and expansion in the skin [11]. Several evidences 
highlighted the association between psoriasis and skin 
microbiota dysbiosis, underlying the relative abundance 
of Corynebacterium, Propionibacterium, Staphylococcus 
and Streptococcus in psoriasis plaques [12].
To date, the specific role of the skin microbiota in pso-
riasis and AD is still unknown, and it is unclear if the 
changes observed in the skin bacterial composition of 
individuals affected by psoriasis and AD are a cause or 
a consequence of alteration of the skin barrier, following 
the pathogenesis of aforementioned skin diseases. Cer-
tainly, the skin microbiota interacts with the host organ-
ism by producing several metabolites, which modulate 
cutaneous pro- and anti-inflammatory responses [13]. 
The current study used a next generation sequencing 
(NGS) approach to determine if some differences in the 
skin microbiota composition occur between individuals 




Three male first cousins aged 50 ± 3 years were chosen 
for the present study, according to specific and strict 
characteristics shared by all of them (Table 1). All subjects 
followed a diet rich in bifidogenic factors that promoted 
the growth of beneficial bacteria, such as bifidobacteria, 
and poor in allergenic foods that could worsening the 
symptomatology of psoriasis and atopic dermatitis. In 
particular, food containing vitamin A (peppers, carrots, 
spinach, basil, pumpkin), vitamin C (orange, lemon, and 
kiwi), folic acid (legumes, cereals, lettuce, asparagus), 
zinc (figs, sunflower seeds, potatoes) and omega-3 (fish) 
were allowed. In contrast, strawberries are often associ-
ated to allergies, in particular to atopic dermatitis, while 
tomato may lead to bowel dysfunction and it is not rec-
ommended for atopic subjects. Therefore, these foods 
were excluded from the diet of subjects enrolled in the 
study. Moreover, shellfish, cheese, fatty foods and red 
meat were not recommended (Table 1).
The selection criteria were chosen in agreement with 
dermatologists of the Clinical Dermatology Unit of 
IRCCS Galeazzi Orthopaedic Institute in Milan, Italy, 
where the study was conducted. One subject was affected 
by moderate AD, one had psoriasis and the last one was 
included as healthy control. The inclusion criteria for 
atopic dermatitis were moderate AD according to Hani-
fin and Rajka [14], with predominant rough and fissured 
skin as well as pruritus for at least 2 months. The inclu-
sion criteria for psoriasis, instead, were the presence 
of psoriatic erythematous patches and the evaluation 
of psoriasis area and severity index (PASI) score, a tool 
used for the measurement of psoriasis severity. In par-
ticular, the PASI score of psoriatic subject enrolled in 
the study was 20.0, while the SCORAD for the AD sub-
ject was 32.46, underlying the presence of a moderate 
psoriasis and a moderate AD, respectively. Furthermore, 
subjects affected by psoriasis and AD had no concomi-
tant diseases and both healthy and psoriatic individual 
had no any history of atopic dermatitis in childhood. The 
primary exclusion factors were the presence of chronic 
dermatosis such as seborrheic dermatitis, contact der-
matitis, nummular eczema, ichthyosis, an immunode-
ficiency or any other immunological disorder, scabies, 
cutaneous fungal infection, HIV-associated skin disor-
ders, malignant diseases, T-cell lymphoma, Letterer-Siwe 
disease, progressive systemic diseases, serious internal 
diseases (e.g., serious decompensated diseases of the 
heart, liver, and/or kidneys, or diabetes mellitus). The 
study was conducted according to ICH guidelines for 
Good Clinical Practice. All procedures followed were in 
accordance with the Declaration of Helsinki of 1975, as 
revised in 2000 and 2008. The study was approved by the 
Ethic Committee and Scientific Direction of the IRCCS 
Galeazzi Orthopaedic Institute. Subjects enrolled in the 
study provided verbal informed consent, which was care-
fully recorded in the study worksheets, to participate in 
the present study. Two lesional skin samples from a dam-
aged area of 2 cm2 behind the left ear were withdrawn by 
mean of a curette from AD and psoriatic subjects. More-
over, two non-lesional skin samples were taken from the 
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same area from AD and psoriatic individuals and used as 
internal control. For the healthy control, instead, two skin 
samples from an area of 2  cm2 behind the left ear were 
withdrawn by mean of a curette. Samples were placed in 
sterile Petri dishes (one dish for each subject’s sample) 
and stored at 4 °C until analysis. Of the two samples, one 
was used for metagenomics, and the other for cultural 
analysis. None of the individuals enrolled in the study 
was currently receiving specific therapy for psoriasis and 
AD (i.e. methotrexate, tacrolimus or pimecrolimus). No 
additional drugs (i.e. corticosteroids, anti-histamines) 
were used by subjects enrolled in the study. In particu-
lar, during the month before the day of sampling, the 
psoriatic individual was subjected to specific clinical 
investigations, such as screening for latent tuberculosis 
and rheumatoid arthritis, to determine the appropriate 
systemic therapy to be administered after the sampling. 
During this period, psoriatic individual could use lanolin, 
a skin protector, if necessary. The study was carried out 
after obtaining informed consent from all subjects, and 
in line with the guidelines for experimental studies on 
humans applicable within our Institute.
DNA extraction
Total DNA was extracted from skin samples using 
the Genomic DNA Mini Kit (Tissue) following the 
manufacturer’s instructions (Geneaid, Italy). The proto-
col included an initial mechanical disruption step with 
a micropestle, followed by an enzymatic lysis incubation 
for 30 min at 60 °C.
16S rRNA gene amplification
Partial 16S rRNA gene sequences were amplified from 
extracted DNA using the 16S Metagenomics Kit (Life 
Technologies, Italy) that is designed for rapid analysis of 
polybacterial samples using Ion Torrent sequencing tech-
nology. The kit includes two primer sets that selectively 
amplify the corresponding hypervariable regions of the 
16S region in bacteria: primer set V2–4–8 and primer 
set V3–6, 7–9. The PCR conditions used were 10 min at 
95  °C, 30 cycles of 30 s at 95  °C, 30 s at 58  °C and 20 s 
at 72 °C, followed by 10 min at 72 °C. Amplification was 
carried out by using a SimpliAmp thermal cycler (Life 
Technologies, Italy). The integrity of the PCR amplicons 
was analyzed by electrophoresis on 2 % agarose gel.
Ion torrent PGM sequencing of 16S rRNA gene‑based 
amplicons
The PCR products derived from amplification of spe-
cific 16S rRNA gene hypervariable regions were puri-
fied by a purification step involving the Agencourt 
AMPure XP DNA purification beads (Beckman Coulter 
Table 1 Subjects’ selection criteria
Subjects’ characteristics
Sex Male
Age 50–53 years old
Subjects relationship All individuals were first cousins
Diet A Mediterranean diet was followed for 1 month before the day sampling. Pollen- and allergen- associated food, such as 
apple, hazelnut, celery, strawberries, shellfish and read meat were excluded from diet. Furthermore, milk intake was not 
recommended. Foods and beverages allowed were: bread, potatoes, vegetables, fresh fruit, meat and meat products, fish 
and fish products, eggs, edible fat, coffee, tea and soft drinks
Lifestyle All individuals lived in the same neighborhood. No sport or daily exercises were practiced during the study period. No travel 
or excursion were carried out for at least 1 month before the day of sampling
Occupation All subjects had a sedentary office work
Sexual activity No sexual activity for 2 weeks before the day of sampling
Clothing All individuals used only cotton clothes for all the study period
Pharmacological therapy No antibiotic therapy was administered for at least 1 month before the day of sampling and they were not subjected to any 
kind of pharmacological therapy
Probiotic therapy No probiotic therapy was administered for at least 1 month before the day of sampling
Personal care All subjects used Cetaphil, a free-preservatives soap, once a day for 1 month before the day of sampling. Cetaphil is an oil-in-
water petrolatum-based cream used to treat dry skin and often recommended for the management of AD. Moreover, no 
skin perfume or cream was used during the study
Others No allergy to food, dust, pollen, grasses and drugs was present
The subjects enrolled in the study shared no genetic diseases
All subjects had not pets and/or contacts with any kind of animals
All individuals were nonsmokers and not subjected to passive smoking
The day of sampling took place the same day for all subjects enrolled in the study. The study was conducted during the 
winter season, in order to avoid excessive sweating
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Genomics, Germany) in order to remove primer dimers. 
From the concentration and the average size of each 
amplicon, the amount of DNA fragments per micro-
liter was calculated and libraries created by using the 
Ion Plus fragment Library kit (Life Technologies, Italy). 
Barcodes were also added to each sample, using the 
Ion Xpress Barcode Adapters 1–16 kit (Life Technolo-
gies, Italy). Emulsion PCR was carried out using the Ion 
OneTouch TM 400 Template Kit (Life Technologies, 
Italy). Sequencing of the amplicon libraries was car-
ried out on a 318 chip using the Ion Torrent Personal 
Genome Machine (PGM) system and employing the Ion 
PGM Hi-Q kit (Life Technologies, Italy) according to 
the supplier’s instructions. After sequencing, the indi-
vidual sequence reads were filtered by the PGM soft-
ware to remove low quality and polyclonal sequences. 
Sequences matching the PGM 3′ adaptor were also 
automatically trimmed. 16 rRNA sequences were then 
analyzed by Ion Reporter Software, which comprises a 
suite of bioinformatics tools that streamline and sim-
plify analysis of semiconductor-based sequencing data. 
The 16S rRNA workflow module in Ion Reporter Soft-
ware was able to classify individual reads combining a 
Basic Local Alignment Search Tool (BLAST) alignment 
to the curated Greengenes database, which contains 
more than 400,000 records, with a BLAST alignment 
to the premium curated MicroSEQ ID database, a high-
quality library of full-length 16S rRNA sequences. The 
final output of Ion Reporter Software was the identifi-
cation of microorganisms and their abundance in the 
sample.
Quantification of Staphylococcus aureus by means 
of cultivable method
Skin samples were transferred to 1.5 ml tubes and one ml 
of normal sterile solution (NaCl 9 g/l) was added. After 
homogenization to a homogeneous solution, samples 
were serially diluted in saline and appropriate dilutions 
were plated onto Mannitol Salt Agar (MSA), a selective 
medium for the growth of Staphylococcus spp, and incu-
bated in aerobiosis for 48 h at 37 °C. All colonies of dif-
ferent morphology were identified according to: growth 
on selective medium, Gram staining, colony and cell 
morphology and the catalase and oxidase tests. The iden-
tification of S. aureus was performed by mean of RAPID 
Staph assay (Thermofisher, Italy). Finally, the percentage 
of occurrence of S. aureus in skin samples was calculated 
as follow:% S. aureus = [mean of CFU/cm2 (S. aureus)]/
[mean of log10 CFU/cm2 (total staphylococci)] × 100.
Statistics
Differences in S. aureus counts between the three indi-
viduals were evaluated by means of Student t test.
Results
Metagenomics analysis of skin microbiota in AD 
and psoriatic individuals and in healthy control
Figures  1, 2 and 3 represent the comparison between 
the cutaneous microbiota of damaged skin from AD 
and psoriatic individuals and the skin of healthy control. 
Comparing lesional skin samples from AD and psoriatic 
subjects to the skin sample of healthy control, the most 
prevalent phyla detected in all subjects included Firmi-
cutes, Bacteroidetes, Proteobacteria and Actinobacteria. 
Subject affected by psoriasis showed a decrease in Fir-
micutes abundance and an increase in Proteobacteria 
abundance, if compared with AD patient and healthy 
individual (Fig.  1). A prevalence of Proteobacteria and 
Bacteroidetes over other phyla has been observed in pso-
riatic individual (Fig. 1). At family level, subject affected 
by psoriasis showed an increase in Streptococcaceae, 
Rhodobacteraceae, Campylobacteraceae, and Moraxel-
laceae if compared with control and AD patient (Fig. 2). 
However, even if psoriatic subject had a larger amount of 
Rhodobacteriaceae, a minor diversity in the family com-
position has been detected (Fig. 3). Indeed, in this subject 
the most abundant genus was Parococcus (i.e. >90  % of 
total Rhodobacteraceae total reads) while in healthy and 
atopic individuals also Rhodobacter and Haematobac-
ter were found in skin microbiota (Fig. 3). Furthermore, 
psoriatic patient showed a decrease in Staphylococcaceae 
and Propionibacteriaceae abundance if compared with 
AD and healthy individual (Fig. 2). In particular, the total 
skin microbiota of psoriatic individual showed a decrease 
in Propionibacterium acnes abundance (i.e. <2 % of total 
reads), while in AD and healthy subject P. acnes was 
more abundant (i.e. >10  % of total reads). Lactobacil-
laceae were the population that contributed in the minor 
proportion to the overall skin microbiota (i.e. <0.5  % of 
total reads). Interestingly, no differences between the 
skin microbiota composition of AD patient and healthy 
control has been observed (Figs.  1, 2). Comparing non-
lesional skin samples from AD and psoriatic subjects to 
the skin sample of healthy control, we did not observed 
any differences in the skin microbiota composition; 
indeed, bacterial phyla (Fig. 4a) and family (Fig. 4b) com-
position in AD and psoriatic individuals was very similar 
to that observed in healthy subject. Furthermore, in non-
lesional skin samples of AD and psoriatic individuals we 
observed a similar composition at genus level among the 
Rhodobacteraceae family, if compared with the healthy 
control (Fig. 4c).
Quantification of S. aureus in skin samples
Patient affected by AD showed the larger abundance of 
S. aureus (Fig. 5a), with a frequency of 73 % of S. aureus 
on the total staphylococci load found on skin sample. By 
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contrast, psoriatic individual had only a 2 % of S. aureus 
on his skin, while healthy control showed a frequency of 
18 % (Fig. 5a). Moreover, no differences in S. aureus fre-
quency were observed between non-lesional skin sam-
ples of AD and psoriatic subjects and healthy control 
(Fig. 5b).
Discussion
This is the first study in which the skin microbiota of 
AD and psoriatic selected individuals subjected to the 
same lifestyle and environment factors has been com-
pared. Indeed, we evaluated the skin microbiota of 
much selected subjects affected by psoriasis and AD, 
compared with the microbiota of a healthy related con-
trol. In particular, we analyzed samples from the area 
behind the left ear, evaluating the microbiota associ-
ated to this specific anatomical district. One of the main 
factor that seem to be involved in the development of 
allergic diseases is the mode of delivery; indeed, cesar-
ean section has been observed to be associated with a 
moderately risk of allergic rhinitis, asthma and hospi-
talization for asthma [15]. One hypothesis concerns the 
composition of the gut microbiota, which is established 
early in childhood. Vaginal delivery leads to the first 
colonization of infant gut with maternal vaginal and 
fecal bacteria, while cesarean babies are deprived of this 
natural exposure and present a different gut microbiota 
[15]. The first steps of infant gut colonization play a piv-
otal role in normal tolerance induction, as well as in the 
development and homeostasis of the immune system. 
Therefore, cesarean delivery may lead to an increased 
susceptibility to atopic conditions. Interestingly, all sub-
jects enrolled in the present study were born by vagi-
nal delivery and no correlations with the development 
of AD and psoriasis can be suggested. However, signifi-
cant differences have been detected in the abundance 
of several bacterial family in subjects enrolled in the 
study. Propionibacteriaceae, indeed, showed a different 
distribution among the three groups analyzed, as AD 
and healthy individuals had a larger abundance of afore-
mentioned bacterial family and its major human species 
Propionibacterium acnes, if compared with the subject 
affected by psoriasis. P. acnes are dominant microor-
ganisms in normal skin [16–19], and a decrease in the 
number of these microbes could be a reflection of dis-
ordered ecological niches that become inhospitable to 
these microorganisms, and probably play a pivotal role 
in the pathogenesis of psoriasis or could be involved in 
the disease worsening [17]. P. acnes could have a benefi-
cial and protective role on the human organism, and in 
particular, at skin level, by mean of its immunomodula-
tory action in signaling human cells [18, 19]. It has been 
hypothesized that P. acnes could protect the human 
skin from the action of several pathogenic bacteria, and 
its decrease could lead to a reduction of the protective 
skin barrier [17]. However, to date it is not clear if the 
decrease observed in P. acnes abundance is a conse-
quence of the inflammatory state of psoriasis, or if this 
reduction is involved in the pathogenesis of the afore-
mentioned disease.
Fig. 1 Relative abundances of bacterial phyla on lesional skin samples of psoriatic and AD individuals and in the skin of healthy control
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An increase in Streptococcaceae has been observed in 
psoriatic subject, confirming data of previous works, in 
which the presence of Streptococcus spp was linked to the 
pathogenesis of psoriasis [20, 21]. Streptococcaceae are 
highly relevant among the environmental factors that are 
involved in the development of psoriasis [21]. Different 
mechanisms, such as molecular mimicry, superantigens 
and the ability of streptococci for intracellular uptake and 
persistence in skin cells, may be involved in the patho-
genesis of the disease. Furthermore, the skin microbiota 
associated to the subject with psoriasis showed a larger 
abundance of Rhodobacteraceae, in comparison to that 
of healthy and AD individual. Interestingly, a minor 
bacterial diversity has been observed in psoriatic sam-
ple, as Paracoccus was the predominant bacterial family 
detected. At the contrary, Rhodobacter and Haematobac-
ter represented a significant part of the skin microbiota 
of AD and healthy subjects. Rhodobacter spp are able to 
produce a molecule, named lycogen, structurally similar 
to lycopene, which can acts as anti-inflammatory agent 
and as inhibitor of melanogenesis. This molecule is able 
to prevent the down-regulation of procollagen I and 
inhibit elevated production of NFκB, a transcription fac-
tor involved in cellular stress, which were elicited by UV-
light exposure [22–24]. The absence of Rhodobacteraceae 
among the skin microbiota observed in psoriatic individ-
ual could be linked to the reduction of the physiological 
skin barrier integrity that is involved in the symptomatol-
ogy and etiopathology of psoriasis.
Finally, our results did not underline a difference 
between the microbiota composition of AD individual 
and the healthy control, except for the higher frequency 
of occurrence of S. aureus in AD subject, even if a high 
abundance of Staphylococcaceae has been detected in 
both groups of individuals. Several evidences exist about 
the mainly role of S. aureus in the pathogenesis of AD 
[25–27]. In particular, the skin of AD subjects has been 
observed to be more frequently colonized by S. aureus 
if compared to that of healthy control. This microorgan-
ism is able to increase the skin inflammation by mean 
Fig. 2 Relative abundances of bacterial families on lesional skin samples of psoriatic and AD individuals and in the skin of healthy control
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of specific toxins which act as superantigens and, as a 
consequence, they may induce monocytes and lympho-
cytes activation, increasing also the production of several 
pro-inflammatory cytokines [28, 29]. Interestingly, as the 
severity of AD lesions increased, also the load of S. aureus 
has been observed to become higher. Probably, the high 
abundance of S. aureus we detected in AD sample con-
tributed to worsening the skin barrier damages, leading 
to the characteristic skin lesions that affected AD subject 
enrolled in the present study. Moreover, the pivotal role 
of S. aureus in AD was underlined by the low frequency 
of S. aureus in non-lesional skin sample of AD individual, 
compared to the lesional skin sample of the same subject. 
Interestingly, the microbiota composition of non-lesional 
skin belonging to AD and psoriatic individuals was very 
similar to the bacterial composition of sample from the 
healthy control. These findings suggested that the cuta-
neous dysbiosis we observed in psoriatic and AD subjects 
was directly linked to the skin damages that characterize 
psoriasis and AD. Moreover, bacteria belonging to Paro-
coccus genera, which have been observed to be increased 
in psoriasis skin sample, seem to be involved in the for-
mation of skin pustules and they may have a direct role in 
the maintenance and worsening of psoriatic skin lesions 
[30]. Cutaneous bacteria have already been observed to 
be directly involved in the pathogenesis of several skin 
diseases, in particular in psoriasis and AD, where patients 
show a significant difference between the microbiota 
composition of lesional skin and non-lesional skin [31]. 
S. aureus, for example, is thought to play a pivotal role 
in the pathogenesis of these diseases, being involved not 
only in the pathology onset, but also in its progression, 
leading to an exacerbation of inflammatory response 
[31]. Moreover, differences in bacterial composition often 
observed in different skin sites may be directly involved 
in the different severity of cutaneous lesions on specific 
skin areas.
Although, several contradictory data about the specific 
role of cutaneous microbiota exist due to different sam-
pling techniques. Some studies analyze the microbiota 
composition using skin swabs, while others investigate 
the bacterial composition from the complete epidermis 
and dermis, leading to different results [31]. To date, there 
are no enough information about the specific role of the 
skin microbiota in cutaneous diseases, as it is not clear if 
the bacterial dysbiosis often associated to these dyseases 
is the leading cause or a consequence of the pathologi-
cal status. Interestingly, several evidences underlined that 
also intestinal bacteria seem to be directly involved in the 
onset and in the maintenance of allergic diseases, sug-
gesting the possibility of preventing or treating AD and 
psoriasis by influencing the intestinal microbiota. The gut 
dysbiosis, associated to disruption of intestinal barrier 
function, may lead to a significant increase in local and 
systemic inflammation that is often associated to aller-
gic diseases [32, 33]. AD patients, in particular, showed 
several changes in the gut microbiota composition, as 
bifidobacteria were significantly lower in comparison to 
Fig. 3 Relative abundances of bacterial genera among Rhodobacteraceae family on lesional skin samples of psoriatic and AD individuals and in the 
skin of healthy control
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Fig. 4 Comparison between non-lesional skin samples of AD, psoriatic and healthy subjects. Comparison between bacterial phyla composition (a); 
comparison between bacterial family composition (b); comparison between bacterial genera composition among Rhodobacteraceae family (c)
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healthy subjects, while the number of staphylococci was 
significantly higher in AD individuals compared with 
controls. Consequently, a decrease of anti-inflammatory 
molecules due to the reduction of bifidobacteria and a 
parallel increase in pro-inflammatory molecules due to 
the proliferation of staphylococci in the intestinal envi-
ronment, may lead to the worsening of inflammation sta-
tus and symptomatology of allergic diseases [32].
Conclusions
In conclusion, significant differences between the skin 
microbiota of psoriatic individual and healthy and AD 
subjects were observed. The majority of studies on AD- 
and psoriasis-associated skin microbiota focused their 
attention on the microbial population belonging to 
shoulder, finger, arm, forearm, elbow, abdomen, knee and 
leg, while we analyzed the area behind the left ear, high-
lighting how the skin area analyzed also could influence 
the microbiota composition in psoriasis and AD.
The forearm, for example, has been observed to be colo-
nized mainly by microorganisms belonging to Proteobac-
teria and Bacteroidetes phyla, as well as the antecubital 
fossa that present also a high abundance of Staphylococ-
caceae. In popliteal fossa, instead, the most abundant 
microorganisms belong to the Staphylococcaceae fam-
ily, while the inguinal crease is colonized mainly by 
Corynebacterineae [30]. Interestingly, the different skin 
sites present not only different kind of microorganisms, 
Fig. 5 Frequency of S. aureus recovery on the lesional skin samples of psoriatic and AD individuals and on the skin of healthy control (a); frequency 
of S. aureus recovery on the non-lesional skin samples of psoriatic, AD and healthy individuals (b). Differences were considered statistically signifi-
cant at p value <0.05
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but they differ also for evenness and richness of bacterial 
communities [34]. Consequently, when a dysbiosis of the 
skin microbiota occurs, the kind of bacteria located on 
various skin sites can differently influence the onset and 
the progression of cutaneous diseases.
However, one limit of the present study was the low 
number of subjects enrolled, but our purpose was to min-
imize all variables that could influence the skin micro-
biota composition, applying stringent criteria of patient 
selection. Moreover, another vial of the present study was 
the lack of information about the family history of AD 
and psoriasis in the maternal or paternal line. However, 
the choice to enroll these three correlated-individuals 
with similar lifestyle have been taken to reduce the study 
variables, as previous studies enrolled subjects with dif-
ferent lifestyles and geolocation that could influence the 
skin microbiota composition. Further analysis will be 
needed to examine greater number of lesions in order to 
evaluate the connection of skin microbiota composition 
with the progression of inflammatory diseases. Further-
more, also patients with severe AD might be involved 
in the study to verify the correlation between the skin 
microbiota, and in particular the presence of S. aureus, 
and the disease severity.
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